Back to Test Catalogue

Voltage-Gated Potassium Channel (VGKC) Antibodies, Serum

Test ID: VGKC S

Test

Method

Radioimmunoassay (RIA)

Report Includes

Voltage-Gated Potassium Channel (VGKC) Antibodies

Specimens

Serum

Clinical Utility

Voltage-Gated Potassium Channel (VGKC) Antibody – Limbic encephalitis (LE) is a paraneoplastic neurological syndrome often associated with small cell lung carcinoma and more rarely with testicular, breast, and other tumors. Clinical hallmarks of paraneoplastic limbic encephalitis are changing mental status, short-term memory impairment, seizures, confusion, and behavioral changes. Hu antibody-negative LE patients usually do not develop symptoms beyond the limbic system and appear to improve more often after treatment of the cancer than those who have Hu antibodies, suggesting that the pathogenesis of the LE in both groups could be different. Recent studies have detected antibodies to voltage-gated potassium channels (VGKC) in patients with LE, with and without associated tumors. Neurological symptoms were found to improve with a reduction of VGKC antibody levels.

Test Location

Quest Diagnostics, California USA

Test Version

28-Nov-2019

Specimen

Specimens

Serum

Sample Volume

1.0 mL

Minimum Volume

0.5 mL

Collection & Handling

Handling Information

Store and send frozen

Stability

Ambient 48 hours
Refrigerated 48 hours
Frozen 73 days

Test Version

28-Nov-2019

Performance / Interpretation

Method

Radioimmunoassay (RIA)

Turnaround Time

14 days

Results

Name Units Reference Range Conversion Factor
Voltage-Gated Potassium Channel (VGKC) Antibodies pmol/L
  • <80

Test Location

Quest Diagnostics, California USA

Test Version

28-Nov-2019

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
VGKC S 63125VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB pmol/L

Test Version

28-Nov-2019